URGN: Pangali rega marang bathi tumrap wutah urogen.com
UroGen Pharma Ltd. (URGN) focuses on urological oncology, mitigating narrow portfolio risks through the success of its first drug. The growth company undervaluation metric reflects the asset's value dynamics, where the current mark is 0.00. A unique drug delivery method provides a competitive edge, enabling the company to maintain pricing power. Meanwhile, operational stability is based on the utilization of external contract manufacturing organizations in the US and Israel.
urogen.com (URGN) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal UroGen Pharma Ltd.|URGN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal UroGen Pharma Ltd|URGN - Utang perusahaan|Rasio utang marang aset resik UroGen Pharma|URGN - Utang jangka dawa perusahaan|Utang jangka cendhak UroGen Pharma|Likuiditas kritis urogen.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
URGN - Bathi resik|Bathi resik sing dikarepake UroGen Pharma Ltd.|URGN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep UroGen Pharma|URGN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan UroGen Pharma|URGN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan UroGen Pharma|URGN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan urogen.com|URGN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep UroGen Pharma Ltd.
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:UroGen Pharma Corp, URGN
This indicator compares the market value of a share with the growth rate of earnings per share, identifying an undervalued asset when the value falls below one. For UroGen Pharma Ltd. (URGN), which is developing innovative gel-based cancer therapies, the PEG ratio allows for an assessment of how much the current price reflects the long-term commercialization potential of these technologies.
Pesaing UroGen Pharma Ltd.
Pangali rega marang bathi tumrap wutah BeiGene Ltd ONC|Pangali PEG HALO (halozyme.com)|RVMD - Pangali rega marang bathi tumrap wutah|AAPG: Pangali rega marang bathi tumrap wutah|CGON - Pangali PEG|Bicara Bio (BCAX) - Rasio rega marang bathi tumrap wutah|Personalis Corp - Koefisien bali modal nimbang wutah|ERAS (Erasca Inc) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Delcath Systems, Inc. DCTH|Pangali rega marang bathi tumrap wutah YMAB (Y-mAbs Corp)|Pangali PEG Aura Bio (AURA)|Pangali PEG CADL (Candel Therapeutics Inc.)|ARAY - Pangali rega marang bathi tumrap wutah|SLS - Rasio rega marang bathi tumrap wutah|Actuate Therapeutics - Rasio nilai perusahaan marang wutah bathi|CTOR: Pangali PEG|TuHURA (HURA) - Pangali PEG|TARA (Protara Therapeutics Inc) - Pangali PEG|FATE: Koefisien bali modal nimbang wutah|Pangali PEG WHWK|TCRX (TScan) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Champions Oncology, Inc. CSBR|XBIT - Pangali rega marang bathi tumrap wutah|CEL-SCI - Pangali PEG|OSTX - Pangali PEG|Radiopharm Theranostics Limited (RADX) - Rasio rega marang bathi tumrap wutah|ARTV - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah ANL|Rasio rega marang bathi tumrap wutah VERU|Pangali PEG TPST|XLO: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG RENB (Renovaro Inc.)|Mural Bio (MURA) - Rega marang bathi kanthi panyesuaian wutah|Kairos Pharma Ltd - Pangali PEG|Rasio kapitalisasi marang bathi lan wutah OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio rega marang bathi tumrap wutah|CRIS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah APLM|Tharimmune (THAR) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah ADVB (Advanced Biomed Inc.)|Genprex - Rasio P/E diaturake wutah|Pangali PEG CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Pangali rega marang bathi tumrap wutah|Xenetic Bio - Pangali PEG|SLRX - Pangali PEG|PPBT: Pangali PEG|Rasio P/E diaturake wutah AONC|BGNE (BeiGene Ltd) - Pangali PEG|CKPT (Checkpoint Therapeutics, Inc) - Rasio nilai perusahaan marang wutah bathi|Pangali PEG ELEV|Pangali rega marang bathi tumrap wutah iCAD Corp ICAD|Rasio rega marang bathi tumrap wutah ikenaoncology.com IKNA|NTBL - Pangali rega marang bathi tumrap wutah|VIRX - Rasio rega marang bathi tumrap wutah|MOR - Pangali PEG|NAYA: Pangali PEG|Ascentage Pharma Group (AAPGV) - Pangali PEG
